Market Turbulence Hits Tech: Why Today's Biggest Stock Losers Reveal a Shifting Sentiment

The Broader Picture: AI Optimism Fades

Thursday’s trading session told an interesting story about investor psychology. While Nvidia’s better-than-expected quarterly earnings initially sparked enthusiasm across the market, the rally fizzled as quickly as it arrived. This reversal suggests a deeper concern: how sustainable is the current AI-driven bull run?

The numbers tell the tale. The Nasdaq Composite dropped 2.15% (-486 points), outpacing losses in the S&P 500 (-1.56%, -103 points) and Dow Jones (-0.84%, -387 points). When growth-heavy indices fall harder than the broader market, it signals profit-taking in exactly the sectors that had climbed highest.

Winners Defying the Trend

Not every stock followed the market downward. Two standout performers captured investor attention for very different reasons.

PACS Group’s Remarkable 56% Surge

PACS Group (NYSE: PACS) dominated today’s biggest stock gainers list with a staggering 56% jump. The catalyst? Resolution of a long-standing uncertainty. After weeks of investigation, the skilled care facility operator announced that its audit committee had completed its review of past financials, clearing the path for the company to regain SEC compliance.

What made this particularly impactful was the underlying business performance. Third-quarter revenues climbed 31% year-over-year to $1.34 billion, with net income reaching $52.3 million—more than tripling its year-ago figure. Investors who had been sidelined by regulatory concerns finally had the green light to re-enter the position.

Exact Sciences Surges on Acquisition News

Exact Sciences (NASDAQ: EXAS) posted a 17% gain after healthcare conglomerate Abbott Labs (NYSE: ABT) announced plans to acquire the cancer screening specialist for $105 per share—a 22% premium to Wednesday’s close. For Exact Sciences shareholders, the deal represents a return to valuations unseen since 2021. The synergy potential is clear: Abbott gains the popular Cologuard product line while expanding its cancer diagnostics portfolio.

Today’s Biggest Stock Losers Paint a Different Picture

The declines were equally dramatic for companies facing headwinds, offering a cautionary counterpoint to the gains.

Bath & Body Works Disappoints on Multiple Fronts

Bath & Body Works (NYSE: BBWI) plummeted 25% following its third-quarter earnings release. The retail company reported quarterly sales down 1% year-over-year to $1.59 billion, but earnings compression was the real concern—falling to $0.37 per share from $0.49 a year earlier.

Looking ahead offers little comfort. Management now anticipates full-year 2025 net sales will decline and earnings will drop substantially versus 2024. The holiday quarter outlook appears particularly weak, with guidance pointing to high-single-digit percentage sales declines and earnings potentially 20% below last year’s fourth quarter. In an environment of tariff uncertainty and consumer caution, Bath & Body Works faces a challenging path forward.

SanDisk’s AI-Driven Rally Reverses

SanDisk (NASDAQ: SNDK) fell 20% despite receiving what would normally be positive news—Bank of America Securities lifted its price target by $30 to $300 per share. The problem? SanDisk had become almost synonymous with the AI boom, rocketing from $50 in early September to nearly $300 by mid-November.

With investors reassessing their exposure to AI-adjacent plays, SanDisk’s pullback reflects a broader cooling toward data storage and semiconductor companies that benefited most from AI enthusiasm. The stock had simply run too far, too fast.

What This Reveals About Market Dynamics

Thursday’s action illustrates a market in transition. The initial wave of AI optimism has given way to questions about valuation, sustainability, and which companies will actually profit from the technology’s adoption. Meanwhile, companies resolving operational uncertainties—like PACS—or offering M&A optionality—like Exact Sciences—found buyers willing to step in.

Today’s biggest stock losers serve as a reminder that momentum alone doesn’t sustain rallies. Bath & Body Works and SanDisk both face structural or valuation challenges that overshadow near-term catalysts.